Drug metabolite concentration‐time profiles: influence of route of drug administration.
Open Access
- 1 April 1984
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 17 (4) , 385-394
- https://doi.org/10.1111/j.1365-2125.1984.tb02362.x
Abstract
In order to assess the contribution of an active metabolite to the overall pharmacological response following drug administration it is necessary to characterise the metabolite concentration-time profile. The influence of route of drug administration on metabolite kinetics has been investigated by computer simulation. Comparisons between simulated profiles and published concentration-time data have been carried out. A route dependence in metabolite concentration-time curves is readily apparent provided the metabolite kinetics are formation rate limited and the hepatic clearance of drug is greater than 25 l/h (medium to highly cleared). Oral drug administration produces a triphasic metabolite concentration-time profile whereas only two phases are discernable after intravenous drug administration. The magnitude of the difference in maximum metabolite concentration is directly proportional to the hepatic clearance of drug due to first-pass metabolite production. The route dependence in the shape of the metabolite concentration-time curves is most dramatic when the absorption and distribution of drug and the elimination of metabolite is rapid. A reduction in the rate of either of these processes alters the shape of the metabolite concentration-time profile such that the consequence of first-pass metabolite formation may be reduced.This publication has 33 references indexed in Scilit:
- Pharmacologically Active Metabolites of Drugs and Other Foreign Compounds Clinical, Pharmacological, Therapeutic and Toxicological ConsiderationsDrugs, 1982
- Pharmacokinetics of triamterene and its metabolite in manJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Combined High-performance Liquid Chromatographic Procedure for Measuring 4-hydroxypropranolol and Propranolol in Plasma: Pharmacokinetic Measurements Following Conventional and Slow-Release Propranolol AdministrationJournal of Pharmaceutical Sciences, 1981
- Metabolite pharmacokinetics: The area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolitesJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Drug Metabolites in Renal FailureClinical Pharmacokinetics, 1981
- Impact of Active Metabolites on Monitoring Plasma Concentrations of Therapeutic DrugsTherapeutic Drug Monitoring, 1980
- Sequential first-pass elimination of a metabolite derived from a precursorJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Influence of Food and Fluid Ingestion on Aspirin BioavailabilityJournal of Pharmaceutical Sciences, 1978
- Pharmacologically Active Drug MetabolitesClinical Pharmacokinetics, 1976
- Absorption Kinetics of Aspirin in Man follow Oral Administration of an Aqueous SolutionJournal of Pharmaceutical Sciences, 1972